Clinical Trial Update: Predicting the Risk of Diabetic Neurodegenerative Disorders by Artificial Intelligence Tools Based on Retinal Imaging

View source ↗

Summary

A clinical trial is evaluating AI-based retinal imaging to predict the risk of diabetic neurodegenerative disorders, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Diabetes Mellitus

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Diabete Mellitus, Cognitive Impairment | Status: RECRUITING